Suivre
François Montastruc, MD, PhD
François Montastruc, MD, PhD
Department of Clinical and Medical Pharmacology Toulouse, TMBI, Univ. Toulouse
Aucune adresse e-mail validée
Titre
Citée par
Citée par
Année
Pharmacovigilance, risks and adverse effects of self-medication
JL Montastruc, E Bondon-Guitton, D Abadie, I Lacroix, A Berreni, ...
Therapies 71 (2), 257-262, 2016
1432016
Trends in first gabapentin and pregabalin prescriptions in primary care in the United Kingdom, 1993-2017
F Montastruc, SY Loo, C Renoux
Jama 320 (20), 2149-2151, 2018
1182018
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
A Touafchia, H Bagheri, D Carrié, G Durrieu, A Sommet, L Chouchana, ...
Clinical Microbiology and Infection 27 (5), 791. e5-791. e8, 2021
1112021
Potentially inappropriate medication use among patients with Alzheimer disease in the REAL. FR cohort: be aware of atropinic and benzodiazepine drugs!
F Montastruc, V Gardette, C Cantet, A Piau, M Lapeyre-Mestre, B Vellas, ...
European journal of clinical pharmacology 69, 1589-1597, 2013
1002013
Serotonin syndrome: analysis of cases registered in the French pharmacovigilance database
D Abadie, V Rousseau, S Logerot, J Cottin, JL Montastruc, F Montastruc
Journal of clinical psychopharmacology 35 (4), 382-388, 2015
992015
Cancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analyses
G Moulis, A Sommet, J Bene, F Montastruc, L Sailler, JL Montastruc, ...
PLoS One 7 (11), e48991, 2012
912012
What is pharmacoepidemiology? Definition, methods, interest and clinical applications
JL Montastruc, J Benevent, F Montastruc, H Bagheri, F Despas, ...
Therapies 74 (2), 169-174, 2019
902019
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
A Revet, F Montastruc, A Roussin, JP Raynaud, M Lapeyre-Mestre, ...
BMC psychiatry 20, 1-13, 2020
862020
Hepatic disorders with the use of remdesivir for coronavirus 2019
F Montastruc, S Thuriot, G Durrieu
Clinical Gastroenterology and Hepatology 18 (12), 2835-2836, 2020
812020
Adverse drug reactions to self‐medication: a study in a pharmacovigilance database
A Berreni, F Montastruc, E Bondon‐Guitton, V Rousseau, D Abadie, ...
Fundamental & clinical pharmacology 29 (5), 517-520, 2015
692015
Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: a systematic review and meta-analysis
G Moulis, A Audemard-Verger, L Arnaud, C Luxembourger, F Montastruc, ...
Autoimmunity reviews 15 (3), 203-209, 2016
652016
Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: a pharmacoepidemiological-pharmacodynamic study in VigiBase
F Montastruc, A Palmaro, H Bagheri, L Schmitt, JL Montastruc, ...
European Neuropsychopharmacology 25 (10), 1556-1565, 2015
642015
Abatacept in rheumatoid arthritis and the risk of cancer: a world observational post-marketing study
S de Germay, H Bagheri, F Despas, V Rousseau, F Montastruc
Rheumatology 59 (9), 2360-2367, 2020
562020
Exposure to atropinic drugs and frailty status
F Moulis, G Moulis, L Balardy, S Gérard, F Montastruc, S Sourdet, ...
Journal of the American Medical Directors Association 16 (3), 253-257, 2015
562015
The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France
F Montastruc, A Sommet, E Bondon-Guitton, G Durrieu, E Bui, H Bagheri, ...
European journal of clinical pharmacology 68, 767-775, 2012
562012
Fatal adverse drug reactions: a worldwide perspective in the World Health Organization pharmacovigilance database
JL Montastruc, M Lafaurie, C de Canecaude, G Durrieu, A Sommet, ...
British journal of clinical pharmacology 87 (11), 4334-4340, 2021
542021
Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database
C Lacroix, F Kheloufi, F Montastruc, Y Bennis, V Pizzoglio, J Micallef
Journal of the Neurological Sciences 398, 196-201, 2019
542019
A comparative study of QT prolongation with serotonin reuptake inhibitors
A Ojero-Senard, J Benevent, E Bondon-Guitton, G Durrieu, L Chebane, ...
Psychopharmacology 234, 3075-3081, 2017
522017
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
D Abrahami, A Douros, H Yin, HY Oriana, JL Faillie, F Montastruc, ...
bmj 363, 2018
512018
Psychiatric disorders and hydroxychloroquine for coronavirus disease 2019 (COVID-19): a VigiBase study
P Garcia, A Revet, A Yrondi, V Rousseau, Y Degboe, F Montastruc
Drug Safety 43, 1315-1322, 2020
472020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20